Phenoxybenzamine partially inhibits alpha 2-adrenoceptors without affecting their presynaptic function.

Area of Science:

• Neuropharmacology
• Adrenergic Receptor Research

Background:

• Alpha-adrenoceptors play crucial roles in central nervous system functions.
• Understanding adrenoceptor turnover is vital for developing targeted therapeutics.

Purpose of the Study:

• To determine the turnover rates of alpha 1- and alpha 2-adrenoceptors in rat cerebral cortex.
• To investigate the functional role of phenoxybenzamine-blocked alpha 2-adrenoceptors.

Main Methods:

• Irreversible blockade of alpha-adrenoceptors using phenoxybenzamine (PBZ) in rats.
• Measurement of [3H]prazosin, [3H]clonidine, and [3H]rauwolscine binding to assess receptor reappearance.
• Assessment of K+-induced [3H]noradrenaline release from cortical synaptosomes.

Main Results:

• Alpha 1-adrenoceptor half-life was 1.87 days, with 95% binding inhibition by PBZ.
• Alpha 2-adrenoceptor binding was only 30% inhibited by PBZ, with a recovery half-life of 12 hours.
• PBZ-blocked alpha 2-adrenoceptors did not affect clonidine's inhibition of noradrenaline release, indicating they are not functional presynaptic autoreceptors.

Conclusions:

• Alpha 1-adrenoceptors exhibit a relatively rapid turnover rate in the rat cerebral cortex.
• A significant population of alpha 2-adrenoceptors is not blocked by phenoxybenzamine and does not function as presynaptic autoreceptors.